Efficacy and Safety of BIA 9-1067 in Idiopathic Parkinson's Disease Patients.

NCT01227655 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

427

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson's Disease

Interventions

DRUG: BIA 9-1067
DRUG: Placebo
DRUG: Levodopa
DRUG: Carbidopa
DRUG: Benserazide

Sponsor

Bial - Portela C S.A.